EconomyNovo’s new strategy hinges on something it can’t manufacture: investor trust
Novo Nordisk CEO Mike Doustdar told CNBC that the company has reached a point where it can broaden its ambitions again, but investors remain unconvinced.
Novo’s new strategy hinges on something it can’t manufacture: investor trust
Economy